NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul A. MahonEVP GENERAL COUNSEL2025-05-01870$295.12
$256.76kSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-01239$297.00
$70.98kSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-01300$298.05
$89.42kSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-01500$299.05
$149.52kSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-011,320$300.63
$396.83kSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-013,392$301.81
$1.02MSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-013,859$302.71
$1.17MSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-01120$303.38
$36.41kSell
Paul A. MahonEVP GENERAL COUNSEL2025-05-0111,000$117.76
$1.30MBuy
Paul A. MahonEVP GENERAL COUNSEL2025-05-01400$296.00
$118.40kSell

1 of 107

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Wealthfront Advisers LLC40.60%18,314,300$5.52BInstitution
Blackrock Inc11.88%5,358,332$1.62BInstitution
Lilly Co Eli11.64%5,251,394$1.58BInsider
Vanguard Group Inc9.85%4,441,823$1.34BInstitution
Avoro Capital Advisors LLC6.12%2,760,300$832.01MInstitution
Wellington Management Group LLP5.46%2,463,891$742.67MInstitution
State Street Corp4.88%2,199,994$663.12MInstitution
Renaissance Technologies LLC4.63%2,089,392$629.78MInstitution
Fmr LLC3.26%1,471,405$443.51MInstitution
Geode Capital Management LLC2.52%1,138,292$343.10MInstitution

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR90.81%9.19%Net SellingNet Buying
GMAB91.82%0.00%
INSM83.58%16.42%Net SellingNet Selling
INCY76.18%23.82%Net SellingNet Selling
BMRN95.48%1.71%Net SellingNet Selling

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 137.96% institutional shareholders, 13.95% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 11.64% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $1.63B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.